Market Place
Sourcing Support
All News #Library
Biotech
Aktis to Present AKY-2519 Dosimetry Data at 2026 ASCO
21 Apr 2026 //
GLOBENEWSWIRE
Aktis Oncology Secures FDA INDs for AKY-2519, Shares Update
30 Mar 2026 //
GLOBENEWSWIRE
Aktis Oncology Receives FDA Fast Track Designation for AKY-1189
24 Feb 2026 //
GLOBENEWSWIRE
Aktis Oncology To Present At Upcoming March Investor Conferences
24 Feb 2026 //
GLOBENEWSWIRE
Vida Ventures Applauds Aktis Oncology`s Public Market Debut
09 Jan 2026 //
BUSINESSWIRE
Aktis Aims For $209M Windfall From 1St Biotech IPO Of 2026
05 Jan 2026 //
FIERCE BIOTECH
Big Pharma-Backed Aktis Plans IPO To Fund Radiopharma Trials
22 Dec 2025 //
FIERCE BIOTECH
Aktis Oncology files for US IPO as biotech listings rebound
19 Dec 2025 //
REUTERS
Aktis Oncology Appoints Kyle Kuvalanka as Chief Financial Officer
05 Nov 2025 //
CONTRACTPHARMA
Aktis Oncology Appoints Industry Veteran Mike Sherman to Board
08 Aug 2025 //
PR NEWSWIRE
Aktis Starts Ph1b Trial Of Nectin-4 Radiopharma AKY-1189
28 May 2025 //
PR NEWSWIRE
Aktis Oncology Appoints Mary Thistle to its Board of Directors
04 Feb 2025 //
PR NEWSWIRE
Lilly-partnered radiopharma startup Aktis Oncology raises $175M
01 Oct 2024 //
BIOPHARMADIVE
Aktis Oncology To Attend Morgan Stanley Healthcare Conference
28 Aug 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.